DNA
#2977
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
7.0 4 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.44%
Variación mensual
-23.06%
Variación en los últimos 6 meses
+3.68%
Cambio anual
-20.72%
Cierres anteriores
6.9 4
Open
7.0 1
Mínimo
6.9 6
Máximo
7.0 7
Volumen
450
Financials
- Market Capitalization 452.96 M
- Employee 485
- Founded 2008
- CEO Jason Kelly
- Website www.ginkgobioworks.com
- Headquarter Delaware, United States
- FIGI BBG00YPS1KY3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.98
Relación precio/flujo de caja
4.57
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2969 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 5.70 USD | +3.83% | +4.01% | +23.64% | +77.57% | 457.17 M USD | ||
| 2976 |  EVMN Evommune, Inc. Common Stock | 12.50 USD | +0.08% | -10.65% | +7.39% | -27.83% | 453.65 M USD | ||
| 2981 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.48 USD | +7.43% | +7.95% | +51.35% | 0.00% | 451.81 M USD | ||
| 2985 |  OCGN Ocugen, Inc. - Common Stock | 1.32 USD | -0.75% | -7.04% | +3.13% | +26.92% | 447.63 M USD |